← Back to all signals
RESEARCH PAPER ANALYSIS

Clinical and Ultrasound Features of Normocyclic Non-Hyperandrogenic Adolescents in Early Gynecological Life.

AI interpretation is pending for this paper.

Open original publication →
PMID39647477
JournalGynecologic and obstetric investigation
Publication Date2024-12-06
Ingested2026-08-02 12:03 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVE: This study aimed to determine the prevalence of polycystic ovarian morphology (PCOM) in healthy postmenarcheal girls and assess whether it represents a crucial physiological phase in gynecological development. Additionally, it evaluated if an elevated stromal-to-surface area (S/A) ratio could identify individuals at risk of developing polycystic ovarian syndrome (PCOS). DESIGN: This is an observational cross-sectional study. PARTICIPANTS: A total of 302 healthy postmenarcheal girls aged 14-18 were included in the study. SETTING: The study was conducted at the Pediatric and Adolescent Gynecology Service of the University Hospital Duilio Casula, Monserrato, University of Cagliari, from 2020 to 2023. METHODS: Participants were divided into three groups: normal ovarian morphology (NOM), PCOM with normal S/A ratio (PCOM-NS), and PCOM with increased S/A ratio (PCOM-IS). Anthropometric, clinical, hormonal, and ultrasound (US) characteristics were analyzed. RESULTS: The overall prevalence of PCOM was 43% (95% CI: 0.37-0.49). Among 302 subjects, 171 (57%) exhibited NOM, 90 (30%) showed PCOM-NS, and 41 (13%) had PCOM-IS. The age and years of postmenarcheal life were significantly lower in the PCOM-NS group than in the NOM group. PCOM-NS exhibited a higher waist-to-hip ratio, hirsutism prevalence, and follicle count per ovarian section. PCOM-IS was associated with elevated androgen levels. A significant reduction in the PCOM pattern was observed after the third postmenarcheal year, while the NOM pattern increased significantly beyond 5 years postmenarche. LIMITATIONS: The study is limited by its cross-sectional design, which precludes establishing causality. Additionally, the exclusion of certain participants due to technical limitations in US evaluation may introduce selection bias. CONCLUSIONS: PCOM may represent a normal physiological phase in ovarian development during early adolescence, predominantly observed in the first 1-3 years postmenarche. An increased S/A ratio could help identify adolescents who may benefit from monitoring for potential PCOS development.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Clinical features and imaging diagnostic challenges of fetus-in-fetu associated with abdominal cryptorchidism: a case report. BMC pediatrics 49.0 2 [Exploring therapeutic mechanism of Compound Pien Tze Huang Tablets for adenoid hypertrophy in children based on network pharmacology and animal experiments]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 59.39 3 Actinomyces odontolyticus Infection of a Marsupialized Vallecular Cyst in a Two-Month-Old Infant: A Report of a Rare Case. Cureus 47.9 4 Further assessment of structural and social determinant of health effects on breast cancer care timelines: a qualitative study. Frontiers in oncology 61.9 5 Case Report: STAT3 hyper-IgE syndrome in children: two cases report with uncommon complications of tuberculosis and lymphoma. Frontiers in pediatrics 51.4 6 Case Report: Vincristine extravasation managed with amniotic membrane graft in a pediatric patient with Wilms tumor. Frontiers in pediatrics 54.7 7 Epigenetic regulation in medulloblastoma: from tumor heterogeneity to diagnostic, prognostic, and translational applications. Frontiers in molecular neuroscience 60.4 8 Fathers of Children With Cancer: Qualitative Insights and Nursing Implications. Oncology nursing forum 61.4 9 Financial Toxicity Among Family Caregivers of Pediatric, Adolescent, and Young Adult Patients With Cancer: A Qualitative Meta-Synthesis. Oncology nursing forum 60.62 10 Healthcare Access and Utilization in a National Sample of Cancer Survivors With a History of Military Service. Oncology nursing forum 64.0 11 Switching Between Anti-TNFs and Other Biologic Drugs in Paediatric Inflammatory Bowel Disease: A Narrative Review and Practical Clinical Guide. Journal of inflammation research 42.30 12 The clinical, functional and oncological outcomes of patients with giant cell tumour of bone. A long-term review. Journal of orthopaedic surgery (Hong Kong) 43.40 13 Body composition changes and nutritional challenges in children with acute lymphoblastic leukaemia: Perspectives from low-resource settings. The Indian journal of medical research 58.90 14 Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy. JCO global oncology 63.00 15 Crossing Borders for Pathology Capacity Building in a Regional Setting: A Pediatric Oncology Initiative. JCO global oncology 57.5 16 Recognition and Management of Ulcerative Infantile Hemangioma: Risk Factors, Diagnosis, and Prognosis. Pediatric annals 62.8 17 Inborn Errors of Immunity and Hematopoietic Cell Transplantation: Recognition and Pretransplant Management. Pediatric annals 60.0 18 SLFN11 enhances cisplatin sensitivity in pediatric cancer via activation of stress-response and suppression of survival pathways. British journal of cancer 64.74 19 Phenotypic and genotypic characteristics of pediatric patients with neurofibromatosis type 1: a 12-year single-center cohort study. World journal of pediatrics : WJP 62.5 20 Supportive care needs among patients with breast and cervical cancer at a tertiary cancer treatment center in ethiopia: a cross-sectional study. Scientific reports 36.90 21 Laser interstitial thermal therapy in pediatric neurosurgery: a prospective nationwide study on indications, safety, and early outcomes. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 61.00 22 Pediatric T-cell lymphoblastic lymphoma with t(9;17)(q34;q23)-associated N-terminally truncated NOTCH1 activation: a case report. International journal of hematology 47.9 23 Inflammatory Myofibroblastic Tumor of the Central Airways: Case Report and Review of Diagnostic and Therapeutic Strategies. Case reports in pulmonology 51.14 24 Awareness level of cancer risk factors and warning signs among adults in Mansoura District, Egypt. BMC public health 61.0 25 A Three-Component Immune Framework Stratifies Treatment Response and Escalation in Pediatric Hemophagocytic Lymphohistiocytosis: A Prospective Single-Center Cohort Study. Pediatric blood & cancer 73.80 26 What a wonderful world: beyond relapsed pediatric acute myeloid leukemia. Haematologica 51.12 27 Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome. Haematologica 51.66 28 Pediatric-inspired therapy and blinatumomab consolidation improve outcomes in young adults with Philadelphia-like acute lymphoblastic leukemia. Haematologica 58.90 29 Assessment of testicular function in boys with hematological malignancies: a prospective longitudinal study. The Journal of clinical endocrinology and metabolism 65.2 30 Adverse health outcomes across the life course in individuals with six rare bone diseases: a 10-year population-based cohort study. European journal of endocrinology 57.5 31 Telemedicine in pediatric oncology during the COVID-19 pandemic: a cross-sectional questionnaire-based study evaluating the patient perspective. Pediatric hematology and oncology 65.1 32 Prevalence of hearing loss and tinnitus after childhood cancer treatment: a Danish nationwide registry-based study. Acta oto-laryngologica 40.80
PATIENT-FRIENDLY SUMMARY

Clinical and Ultrasound Features of Normocyclic Non-Hyperandrogenic Adolescents in Early Gynecological Life.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic